Advanced search
Start date
Betweenand

Ivan Pereira Nascimento

CV Lattes GoogleMyCitations ResearcherID


Secretaria da Saúde (São Paulo - Estado). Fundação Butantan  (Institutional affiliation for the last research proposal)
Birthplace: Brazil

graduate at Farmácia from Universidade Federal da Bahia (1995), master's at Biochemistry from Universidade de São Paulo (1997) and ph.d. at Biochemistry from Universidade de São Paulo (2002). Has experience in Biochemistry, focusing on Molecular Biology, acting on the following subjects: recombinant bcg, recombinant vaccine, atpase, mycobacterium bovis-bcg and trypanosoma cruzi. (Source: Lattes Curriculum)

Research grants
FAPESP support in numbers * Updated February 15, 2020
Total / Available in English
1 / 1 Completed research grants
2 / 0 Completed scholarships in Brazil
3 / 1 All research grants and scholarships

Associated processes
Contact researcher

Use this Research Supported by FAPESP (BV/FAPESP) channel only to send messages referring to FAPESP-funded scientific projects.


 

 

 

 

Keywords used by the researcher
Scientific publications resulting from Research Grants and Scholarships under the grantee's responsibility (2)

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

Publications2
Citations20
Cit./Article10.0
Data from Web of Science

NASCIMENTO, IVAN P.; DIAS, WALDELY O.; QUINTILIO, WAGNER; HSU, TSUNGDA; JACOBS, JR., WILLIAM R.; LEITE, LUCIANA C. C.. Construction of an unmarked recombinant BCG expressing a pertussis antigen by auxotrophic complementation: Protection against Bordetella pertussis challenge in neonates. Vaccine, v. 27, n. 52, p. 7346-7351, . Web of Science Citations: 17. (96/11539-0)

RODRIGUEZ, DUNIA; GOULART, CIBELLY; PAGLIARONE, ANA C.; SILVA, ELIANE P.; CUNEGUNDES, PRISCILA S.; NASCIMENTO, IVAN P.; BORRA, RICARDO C.; DIAS, WALDELY O.; TAGLIABUE, ALDO; BORASCHI, DIANA; et al. In vitro Evidence of Human Immune Responsiveness Shows the Improved Potential of a Recombinant BCG Strain for Bladder Cancer Treatment. FRONTIERS IN IMMUNOLOGY, v. 10, . Web of Science Citations: 3. (17/24832-6)

Please report errors in researcher information by writing to: cdi@fapesp.br.
X

Report errors in this page


Error details: